Page last updated: 2024-09-03

swertisin and n(6)-cyclopentyladenosine

swertisin has been researched along with n(6)-cyclopentyladenosine in 1 studies

Compound Research Comparison

Studies
(swertisin)
Trials
(swertisin)
Recent Studies (post-2010)
(swertisin)
Studies
(n(6)-cyclopentyladenosine)
Trials
(n(6)-cyclopentyladenosine)
Recent Studies (post-2010) (n(6)-cyclopentyladenosine)
21019605062

Protein Interaction Comparison

ProteinTaxonomyswertisin (IC50)n(6)-cyclopentyladenosine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.2256
Adenosine receptor A2bRattus norvegicus (Norway rat)1.16
Adenosine receptor A1Homo sapiens (human)0.0027
Adenosine receptor A2aRattus norvegicus (Norway rat)1.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jang, DS; Jeon, SJ; Kim, E; Kim, H; Ko, SY; Lee, HE; Lee, S; Lee, Y; Park, SJ; Ryu, B; Ryu, JH1

Other Studies

1 other study(ies) available for swertisin and n(6)-cyclopentyladenosine

ArticleYear
Swertisin, a C-glucosylflavone, ameliorates scopolamine-induced memory impairment in mice with its adenosine A1 receptor antagonistic property.
    Behavioural brain research, 2016, 06-01, Volume: 306

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Apigenin; Avoidance Learning; CHO Cells; Cholinergic Antagonists; CREB-Binding Protein; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Protein Binding; Purinergic P1 Receptor Agonists; Retention, Psychology; Scopolamine

2016